Lurasidone in the treatment of sleep disturbance associated with bipolar depression: post-hoc analysis of a placebo-controlled trial followed by a long-term extension study

被引:0
|
作者
Tsai, J. [1 ]
Thase, M. [2 ]
Siu, C. [3 ]
Pikalov, A. [1 ]
Loebel, A. [1 ]
机构
[1] Sunovion Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[2] Univ Penn, Psychiat, Philadelphia, PA 19104 USA
[3] COS & Associates Ltd, Data Sci, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-167
引用
收藏
页码:121 / 122
页数:2
相关论文
共 50 条
  • [1] Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study
    Loebel, Antony
    Siu, Cynthia
    Rajagopalan, Krithika
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ketter, Terence A.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 376 - 382
  • [2] Lurasidone for bipolar I depression with anxiety: Post-hoc analysis of a randomized, placebo-controlled study
    Hagi, Katsuhiko
    Shima, Hirokazu
    Inoue, Takeshi
    BIPOLAR DISORDERS, 2021, 23 : 70 - 71
  • [3] Lurasidone in children and adolescents with bipolar depression associated with mixed (Subsyndromal Hypomanic) features: post-hoc analysis of a randomized placebo-controlled trial
    Tocco, M.
    Pikalov, A.
    Siu, C.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 67
  • [4] Remission and recovery in lurasidone-treated patients with bipolar depression: post-hoc analysis of a 6-week, placebo-controlled trial followed by a 6-month extension
    Loebel, A.
    Siu, C.
    Rajagopalan, K.
    Pikalov, A.
    Cucchiaro, J.
    Ketter, T.
    BIPOLAR DISORDERS, 2015, 17 : 92 - 92
  • [5] Remission in Lurasidone-treated Patients with Bipolar I Depression: Post-hoc Analysis of a 6-week, Placebo-controlled Trial Followed by a 6-month Extension
    Loebel, A.
    Siu, C.
    Pikalov, A.
    Rajagopalan, K.
    Cucchiaro, J.
    Ketter, T.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [6] Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
    McIntyre, Roger S.
    Cucchiaro, Josephine
    Pikalov, Andrei
    Kroger, Hans
    Loebel, Antony
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (04) : 398 - 405
  • [7] Symptomatic and Functional Remission and Recovery in Lurasidone-treated Patients with Bipolar Depression: Post-hoc Analysis of a 6-week, Placebo-Controlled Trial Followed by a 6-Month Extension
    Loebel, Antony
    Siu, Cynthia
    Rajagopalan, Krithika
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ketter, Terence
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S390 - S390
  • [8] Efficacy and Safety of Lurasidone in a Younger Population With Bipolar Depression: Pooled Post-hoc Analysis of Two Placebo-controlled Studies
    Davey, Chris
    Ratheesh, Aswin
    Tocco, Michael
    Mao, Yongcai
    George, David
    Pikalov, Andrei
    Singh, Manpreet K.
    CNS SPECTRUMS, 2023, 28 (02) : 249 - 249
  • [9] Lurasidone in the treatment of bipolar depression: A post-hoc analysis by duration of illness
    Hagi, Katsuhiko
    Shima, Hirokazu
    BIPOLAR DISORDERS, 2021, 23 : 92 - 93
  • [10] LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION ASSOCIATED WITH MIXED (SUBSYNDROMAL HYPOMANIC) FEATURES: POST HOC ANALYSIS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Pikalov, Andrei A.
    Siu, Cynthia
    Tocco, Michael
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S169 - S169